Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr Endocrinol Metab ; 32(5): 471-478, 2019 May 27.
Article in English | MEDLINE | ID: mdl-31042644

ABSTRACT

Background Thyroid dysfunction is the most common hormonal abnormality in obesity. It should actually be considered as an adaptation response to fat excess. However, little has been reported on the morphology of the thyroid gland, and no data regarding the relationship between thyroid gland changes and metabolic parameters are available in obese adolescents. Objective The study aimed to evaluate the frequency of non-autoimmune thyroiditis in obese adolescents and compare the metabolic status of patients with or without thyroiditis. Methods A total of 218 obese children and 49 age-matched control healthy children were included. Thyroid ultrasonography (USG) was performed in all participants, as well as thyroid hormone levels, thyroid antibodies (Abs), lipid profile, homeostasis model assessment of insulin resistance (HOMA-IR) and high-sensitivity C-reactive protein (HsCRP) were determined. Obese children were divided into three groups according to the presence of thyroid autoantibodies and USG findings of thyroiditis (Group-1: Abs [-], normal thyroid morphology/Group-2: Abs [+], abnormal thyroid morphology/Group-3: Abs [-], abnormal thyroid morphology). The relationship between body mass index, metabolic parameters and thyroid gland status was analyzed. Results Seventy-two of 218 obese patients (33%) had non-autoimmune thyroiditis (Group-3). The rate of insulin resistance was significantly higher in Group-3 than in Group-1 (p = 0.024). Similarly, the frequency of metabolic syndrome (MS) was higher in Group-3 (44.3%) than in Group-1 (27.1%) (p = 0.014). Conclusions Obese adolescents with non-autoimmune thyroiditis had a higher incidence of insulin resistance. This finding supported the hypothesis that insulin resistance may have an effect on thyroid morphology. Further randomized trials investigating this relationship are required.


Subject(s)
Insulin Resistance , Liver/pathology , Pediatric Obesity/complications , Thyroid Gland/pathology , Thyroiditis/etiology , Adolescent , Biomarkers/analysis , Case-Control Studies , Child , Female , Follow-Up Studies , Humans , Liver/diagnostic imaging , Male , Prognosis , Thyroid Gland/diagnostic imaging , Thyroiditis/diagnostic imaging , Thyroiditis/pathology , Ultrasonography
2.
J Clin Res Pediatr Endocrinol ; 11(3): 311-318, 2019 09 03.
Article in English | MEDLINE | ID: mdl-30525344

ABSTRACT

Generalized arterial calcification of infancy (GACI) is a rare autosomal-recessive disorder, characterized by calcification of the internal elastic lamina, fibrotic myointimal proliferation of muscular arteries and resultant arterial stenosis. Treatment with bisphosphonates has been proposed as a means of reducing arterial calcifications in GACI patients, although there is no formalized treatment approach. The case reported here was a patient with severe GACI diagnosed at three months of age who had no response to bisphosphonate treatment, but clinically improved after the initiation of magnesium and anti-phosphate (using calcium carbonate) treatments. In patients unresponsive to bisphosphonate, magnesium and anti-phosphate treatment may be attempted.


Subject(s)
Calcium Carbonate/therapeutic use , Diphosphonates/therapeutic use , Magnesium/therapeutic use , Vascular Calcification/drug therapy , Adult , Antacids/therapeutic use , Bone Density Conservation Agents/therapeutic use , Drug Therapy, Combination , Female , Humans , Infant , Male , Prognosis , Vascular Calcification/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...